89BIO, INC. (ETNB) Social Stream



89BIO, INC. (ETNB): $8.95

0.55 (+6.55%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ETNB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#329 of 345

in industry

89BIO INC (ETNB) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ETNB.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 8 $62 $33 $50.875 $8.04 532.77%
2022-01-25 9 $62 $33 $50.333 $8.04 526.03%
2022-05-04 9 $60 $33 $46.888 $8.04 483.18%
2022-05-12 9 $60 $12 $41.666 $8.04 418.23%
2022-05-13 9 $60 $12 $40.111 $8.04 398.89%
2022-05-16 9 $60 $10 $36.444 $8.04 353.28%
2022-06-06 9 $60 $10 $32.555 $8.04 304.91%
2022-07-11 9 $46 $10 $23.666 $8.04 194.35%
2022-07-28 9 $46 $10 $23.333 $8.04 190.21%
2022-08-12 8 $46 $10 $23.875 $8.04 196.95%
2022-08-15 7 $29 $10 $20.714 $8.04 157.64%
2022-08-16 7 $29 $10 $20.428 $8.04 154.08%
2022-08-19 7 $29 $10 $20.571 $8.04 155.86%
2022-09-17 7 $29 $10 $22.142 $8.04 175.4%
2022-11-14 8 $34 $11 $24 $8.04 198.51%
2022-11-21 8 $34 $11 $23.875 $8.04 196.95%
2023-02-08 8 $34 $12 $24.625 $8.04 206.28%
2023-03-17 8 $34 $17 $25.375 $8.04 215.61%
2023-03-20 8 $34 $17 $25.125 $8.04 212.5%
2023-03-22 7 $45 $17 $27.375 $8.04 240.49%
2023-03-28 8 $50 $24 $34.5 $8.04 329.1%
2023-04-13 8 $50 $24 $33.875 $8.04 321.33%
2023-05-08 8 $50 $24 $34.75 $8.04 332.21%
2023-05-10 8 $50 $24 $34.375 $8.04 327.55%
2023-06-06 8 $50 $24 $34 $8.04 322.89%
2023-06-25 9 $50 $24 $35.666 $8.04 343.61%
2023-06-26 9 $50 $25 $37.5 $8.04 366.42%
2023-07-11 9 $50 $25 $37.444 $8.04 365.72%
2023-08-11 9 $50 $25 $37.333 $8.04 364.34%
2023-08-15 9 $50 $25 $37 $8.04 360.2%
2023-10-10 10 $50 $25 $36.9 $8.04 358.96%
2023-10-11 10 $50 $25 $34.2 $8.04 325.37%
2023-10-12 10 $50 $25 $33.1 $8.04 311.69%
2023-11-10 10 $50 $24 $32.8 $8.04 307.96%
2023-11-27 10 $50 $24 $32.2 $8.04 300.5%

The Trend in the Analyst Price Target


Over the past 22 months, ETNB's average price target has gone down $18.13.

ETNB reports an average of 136.73% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-04 8 34 12 24.625 11.90 106.93%
2023-02-21 8 34 17 25.375 13.89 82.69%
2023-03-17 8 34 17 25.375 12.44 103.98%
2023-06-25 9 50 24 35.666 19.10 86.73%
2023-11-27 10 50 24 32.200 7.63 322.02%

ETNB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.3 8 1 1 0 0 10

The Trend in the Broker Recommendations


Over the past 16 months, ETNB's average broker recommendation rating worsened by 0.19.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • 89BIO INC's upside potential (average analyst target price relative to current price) is higher than 3426.31% of all US stocks.
  • ETNB has a lower variance in analysts' estimates than -3120.09% of all US stocks.
  • In terms of how 89BIO INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 3549.54% of that group.
  • In terms of how 89BIO INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 2865.14% of that group.

Stocks similar to 89BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GRTX, RAPT, and PHAT.

Make investment decisions regarding ETNB using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!